• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON RESEARCH, LLC - HUNTINGTON ACRYSOF IQ NATURAL SINGLEPIECE IOL; INTRAOCULAR LENS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON RESEARCH, LLC - HUNTINGTON ACRYSOF IQ NATURAL SINGLEPIECE IOL; INTRAOCULAR LENS Back to Search Results
Model Number SN60WF
Device Problems Break (1069); Device Dislodged or Dislocated (2923); Scratched Material (3020)
Patient Problems Corneal Edema (1791); Inflammation (1932); Intraocular Infection (1933); Pain (1994); Blurred Vision (2137); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Type  Injury  
Manufacturer Narrative
The product was not returned for analysis.The literature report contained photos which did show the broken distal portion of a haptic.The complaint history and product history records could not be reviewed because the reporter did not provide a lot number or any identification traceable to the manufacturing documentation.Associated products were n provided other than a monarch cartridge was used.Without the lens diopter and the specific products used in cannot be determined if a qualified combination was used.The report contained photos of the broken distal end of a single-piece natural haptic.A determination of root cause for the haptic damage could not be made from the photos.The report stated that haptic fragment had a cut appearance.The report suggested that based on a scratch observed adjacent to the damaged haptic, the damage may have been caused by improper manipulation either during the iol loading, or during release of the iol from the plunger or by a defective surgical implantation device.Not enough information was provided in the report to determine if a qualified iol/delivery system combination was used.Company foldable iols are qualified for use with a company qualified delivery system (handpiece and cartridge) and ophthalmic viscosurgical device (ovd) combination.The manufacturer internal reference number is: (b)(4).
 
Event Description
A physician reported via literature article that two months following a cataract extraction with intraocular lens (iol) implant procedure, the patient began to experience eye irritation, which persisted and worsened over the subsequent months.The patient then began to notice a decrease in vision and the quality of pain became more deep and aching.The patient visited the institution six months after the patient¿s cataract surgery.On initial examination, his best corrected vision was noted to be 20/40 (pinhole to 20/30) in the eye.Slit lamp examination of the eye revealed conjunctival infection and inferior corneal edema extending into the visual axis, inferior descemet¿s folds, and trace cells in the anterior chamber.The iol haptic was noted in the inferior anterior chamber angle lying against the iris and in contact with the corneal endothelium.By ultrasound biomicroscopy, the haptic fragment was located in the inferior angle but did not appear to be contiguous with the remainder of the iol, which was noted to be within the posterior chamber, slightly decentered, with no iris touch.The decision was made to surgically remove the iol fragment and examine the iol position.Intra-operatively, the iol fragment was confirmed to be loose as it shifted position when the patient was supine.The fragment was removed using micro-forceps, and the remainder of the iol was then examined using an endoscope probe.The nasal haptic was noted to be within the capsular bag however, the cut temporal haptic was dislocated out of the capsular bag and fibrosed to the anterior aspect of the anterior capsule.The iol was slightly decentered but stable and therefore was not exchanged.A scratch was also noted on the iol optic in the mid-periphery near the temporal haptic.Post-operatively, the patient¿s corneal edema improved and topical steroids were tapered.At one-month postoperative appointment, patient vision had returned to 20/20 with trace residual inferior corneal edema.The patient has since moved out of state and therefore no long-term follow-up or testing is available.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACRYSOF IQ NATURAL SINGLEPIECE IOL
Type of Device
INTRAOCULAR LENS
Manufacturer (Section D)
ALCON RESEARCH, LLC - HUNTINGTON
6065 kyle lane
huntington WV 25702
Manufacturer (Section G)
ALCON RESEARCH, LLC - HUNTINGTON
6065 kyle lane
huntington WV 25702
Manufacturer Contact
jonathan schlech
6201 south freeway
mail stop ab2-6
fort worth, TX 76134
8175514979
MDR Report Key12683992
MDR Text Key278105996
Report Number1119421-2021-01961
Device Sequence Number1
Product Code HQL
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P930014
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Physician
Type of Report Initial
Report Date 10/22/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/22/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberSN60WF
Device Catalogue NumberSN60WF.XXX
Device Lot NumberASKU
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/26/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Age85 YR
-
-